13-20189319-G-A
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_004004.6(GJB2):c.263C>T(p.Ala88Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A88G) has been classified as Uncertain significance.
Frequency
Consequence
NM_004004.6 missense
Scores
Clinical Significance
Conservation
Publications
- Bart-Pumphrey syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- ichthyosis, hystrix-like, with hearing lossInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- keratoderma hereditarium mutilansInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- palmoplantar keratoderma-deafness syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
- autosomal recessive nonsyndromic hearing loss 1AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- autosomal dominant keratitis-ichthyosis-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics
- autosomal dominant nonsyndromic hearing loss 3AInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- KID syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004004.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GJB2 | NM_004004.6 | MANE Select | c.263C>T | p.Ala88Val | missense | Exon 2 of 2 | NP_003995.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GJB2 | ENST00000382848.5 | TSL:1 MANE Select | c.263C>T | p.Ala88Val | missense | Exon 2 of 2 | ENSP00000372299.4 | ||
| GJB2 | ENST00000382844.2 | TSL:6 | c.263C>T | p.Ala88Val | missense | Exon 1 of 1 | ENSP00000372295.1 | ||
| ENSG00000296095 | ENST00000736390.1 | n.232-3739C>T | intron | N/A |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Autosomal dominant keratitis-ichthyosis-hearing loss syndrome Pathogenic:1
not provided Pathogenic:1
This missense change has been observed in individual(s) with autosomal dominant keratitis–ichthyosis–deafness (KID) syndrome (PMID: 20629838). In at least one individual the variant was observed to be de novo. This sequence change replaces alanine with valine at codon 88 of the GJB2 protein (p.Ala88Val). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and valine. This variant is not present in population databases (ExAC no frequency). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GJB2 protein function. Experimental studies have shown that this missense change affects GJB2 function (PMID: 23447037). For these reasons, this variant has been classified as Pathogenic.
Porokeratotic adnexal ostial nevus Pathogenic:1
A GJB2 c.263C>T (p.Ala88Val) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in a germline state in numerous individuals with keratitis-ichthyosis-deafness (KID) syndrome (Koppelhus U et al., PMID: 20846357; Maarouf S et al., PMID: 39659087; Haruna K et al., PMID: 20629838; Lilly E et al., PMID: 30287322; López-Sundh AE et al., PMID: 36286624) and in four individuals as a somatic variant associated with porokeratotic adnexal ostial nevus (PAON) (Chang YH et al., PMID: 36478599; Zhao A et al., PMID: 38292003; Letertre O et al., PMID: 36734293). It has been reported in the ClinVar database as a pathogenic variant by two submitters (ClinVar ID: 1458348). Other variants at the same codon, p.Ala88Ser, p.Ala88Gly, p.Ala88Glu, and p.Ala88Pro, have been reported in individuals with various non-syndromic recessive conditions and are considered pathogenic (Posukh OL et al., PMID: 37892203). The GJB2 c.263C>T (p.Ala88Val) variant is absent from the general population (gnomAD v.4.1.0), indicating it is not a common variant. It resides within a region, transmembrane domain 2, of GJB2 that is defined as a critical functional domain (Posukh OL et al., PMID: 37892203; Chang YH et al., PMID: 36478599). Computational predictors indicate that the variant is damaging, evidence that correlates with impact on GJB2 function. In support of this prediction, functional studies show that the GJB2 c.263C>T (p.Ala88Val) variant significantly activates hemichannels and increased membrane current flow, resulting in accelerated cell death in low extracellular calcium concentrations (Bayraktar E et al., PMID: 38928300; Mhaske PV et al., PMID: 23447037; Yasarbas SS et al., PMID: 38827992). Based on an internally developed protocol informed by the ACMG/AMP guidelines (Leon-Quintero FZ, et al., PMID: 39434542) and gene-specific practices from the ClinGen Criteria Specification Registry, the GJB2 c.263C>T (p.Ala88Val) variant is classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at